UnitedHealth Group (NYSE:UNH)‘s stock had its “buy” rating reissued by analysts at Raymond James Financial in a report released on Wednesday.

Other analysts have also recently issued research reports about the stock. Sanford C. Bernstein boosted their price target on shares of UnitedHealth Group from $219.00 to $246.00 and gave the stock an “outperform” rating in a research note on Friday, December 1st. Leerink Swann reiterated an “outperform” rating on shares of UnitedHealth Group in a research note on Friday, December 1st. Jefferies Group reiterated a “buy” rating and issued a $248.00 price target on shares of UnitedHealth Group in a research note on Friday, December 1st. Piper Jaffray Companies boosted their price target on shares of UnitedHealth Group to $242.00 and gave the stock an “overweight” rating in a research note on Wednesday, November 29th. Finally, Royal Bank Of Canada boosted their price target on shares of UnitedHealth Group to $244.00 and gave the stock an “outperform” rating in a research note on Wednesday, November 29th. They noted that the move was a valuation call. Three equities research analysts have rated the stock with a hold rating and twenty-four have assigned a buy rating to the company. The stock has an average rating of “Buy” and a consensus target price of $224.56.

Shares of UnitedHealth Group (NYSE:UNH) traded down $1.33 during trading on Wednesday, reaching $220.09. 3,246,300 shares of the company traded hands, compared to its average volume of 3,119,193. The company has a market cap of $214,570.92, a P/E ratio of 23.07, a P/E/G ratio of 1.64 and a beta of 0.66. The company has a debt-to-equity ratio of 0.52, a current ratio of 0.70 and a quick ratio of 0.70. UnitedHealth Group has a one year low of $156.09 and a one year high of $231.77.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Tuesday, October 17th. The healthcare conglomerate reported $2.66 earnings per share for the quarter, topping the consensus estimate of $2.57 by $0.09. The company had revenue of $50.32 billion during the quarter, compared to the consensus estimate of $50.38 billion. UnitedHealth Group had a net margin of 4.50% and a return on equity of 21.52%. UnitedHealth Group’s quarterly revenue was up 8.7% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $2.17 EPS. analysts anticipate that UnitedHealth Group will post 9.99 earnings per share for the current fiscal year.

In related news, insider Larry C. Renfro sold 50,574 shares of the company’s stock in a transaction dated Friday, September 15th. The shares were sold at an average price of $198.11, for a total transaction of $10,019,215.14. Following the transaction, the insider now directly owns 195,625 shares in the company, valued at approximately $38,755,268.75. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Gail R. Wilensky sold 5,600 shares of the company’s stock in a transaction dated Wednesday, November 29th. The shares were sold at an average price of $223.31, for a total transaction of $1,250,536.00. Following the transaction, the director now owns 61,137 shares in the company, valued at $13,652,503.47. The disclosure for this sale can be found here. Insiders have sold a total of 57,606 shares of company stock worth $11,566,525 over the last 90 days. Corporate insiders own 0.89% of the company’s stock.

A number of hedge funds have recently modified their holdings of the business. Institutional & Family Asset Management LLC boosted its stake in shares of UnitedHealth Group by 4.6% during the third quarter. Institutional & Family Asset Management LLC now owns 19,346 shares of the healthcare conglomerate’s stock valued at $3,789,000 after purchasing an additional 857 shares in the last quarter. Steward Partners Investment Advisory LLC bought a new position in shares of UnitedHealth Group during the third quarter valued at approximately $7,787,000. Visionary Asset Management Inc. bought a new position in shares of UnitedHealth Group during the third quarter valued at approximately $309,000. Jana Partners LLC bought a new position in shares of UnitedHealth Group during the third quarter valued at approximately $44,601,000. Finally, Public Employees Retirement System of Ohio boosted its stake in shares of UnitedHealth Group by 1.2% during the third quarter. Public Employees Retirement System of Ohio now owns 711,891 shares of the healthcare conglomerate’s stock valued at $139,424,000 after purchasing an additional 8,769 shares in the last quarter. Institutional investors and hedge funds own 86.20% of the company’s stock.

COPYRIGHT VIOLATION WARNING: “Raymond James Financial Reaffirms “Buy” Rating for UnitedHealth Group (UNH)” was originally reported by American Banking News and is the property of of American Banking News. If you are reading this piece of content on another website, it was copied illegally and republished in violation of U.S. & international copyright and trademark law. The original version of this piece of content can be viewed at https://www.americanbankingnews.com/2017/12/06/raymond-james-financial-reaffirms-buy-rating-for-unitedhealth-group-unh.html.

About UnitedHealth Group

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Analyst Recommendations for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related companies with MarketBeat.com's FREE daily email newsletter.